{"id":1002307,"date":"2026-09-10T07:07:21","date_gmt":"2026-09-10T11:07:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"modified":"2026-09-10T07:07:21","modified_gmt":"2026-09-10T11:07:21","slug":"kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","title":{"rendered":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">REHOVOT, Israel, and HOBOKEN, N.J., Sept.  10, 2026  (GLOBE NEWSWIRE) &#8212; Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate and present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel.<\/p>\n<p align=\"justify\">Mr. London is scheduled to present at the conference on Tuesday, September 15, 2026, at 2:30 p.m. Eastern Time. In addition to the presentation, Mr. London will be available for one-on-one investor meetings throughout the conference. Investors that are interested in arranging a meeting should contact their H.C. Wainwright representative.<\/p>\n<p align=\"justify\">A live webcast and audio archive of the event may be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0vxcmeI_4d9_j0pxGanKzZy8z5GkUuhG1h2Pyw-zTJjCyvK3DGtxakRfrUltQakj9t2H21YKRZ0aTWKgq24yBBngNFeqa7TAU991fGqqDginsmUll6RhVnAeiQj4CU-2Pweo1jXjF5WqdYqffgoOG9fp8zVoTvJ-3JEW_1JrQr6jOdGVJOxS6deoUsfBuoHptPNFC6oblWRmN3t7YTBhizc4MM6YOWUl78oM8QW9a2T5QKhuRE414MPMgUa_ou8Y2JA4VuGf4G9vGeAV8WmjrlNmjhQ8jW1SJamHLVylhjYfXgL_sFyvCN6ugwwyL7_C0Td9-lY4ubOAZs9b0OjVGLb_Xzh0GI5gjvy9s6Ch_2YE1WubTAdtTb5YCTjgws0iVkibRgqf_3ZPD6i4gh9ZFiDVtnfpS2CQU1ahKRZk4XK9sVZOUpramYy_-fpSnW0rD3Dg8bP0y0S4lLzrvASQU2bdSl9nOJBJzdSd2qabKGo7XK-FLuYh3jg-fhYgCrFiohhWZWzhUSai0w62pCG85MDI1p89fO46gs0WWeioCwLarAgOpKiu9-nRJ04Uju9KtVT1YCbGY9tb9TQu6gVz0nvxJ3ysmUX1sPA_yHQ9Ebo8gYpkHjBIXC7XIRwyXP0j-HW-nX6AoRpC6SrGmPfbOdygz0bOdrmHmwW_6zAAbYt3x4p9KPKKtoGXCASIFqczo7U9gc1YXG2C51JrhQsJh_q7emP434LwK6WWeOSOkyiyqDRI9PQo5f78RaKnIMEA_Q2RbUF7Fqnk4un11OE-votBDqie0nmByBvjWFnn67WRLzTerhncaE7TFeOKDMCJSycO3ZAkvhzuo-ya82Z7HTUiE79trpF9uxExIQ68CyeZrG5wXahRsHw_3A30EkUHrgPwCXoZWrR-j97HSLAenGEf5oZS806fCad_6K1Oj79eQA1GV-jR0oCgJcJyob7imT2vqsxnkpdWmB80kxYH1u-WW_z29ukxbkx15AZA0Mc19_fSbi8T8zfQV1soUPM1vLmEg2CmcFjW49et9wiiwTRgG4aYfciDOP4VpR3F-ec=\" rel=\"nofollow\" target=\"_blank\"><strong>here<\/strong><\/a> (the full link appears below as well) and through the investor relations section of Kamada\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QPPQ3jDLzmVDekQgsQkoYhOnGNFxiy0iM4AZUwFGy32eLR3Obtr7eU_YtIeR0Xu-10aXjdjyK-SE03OfAVVQc7n_vEgIumfUw_KSplOmVcCVeOXTEQNBGWa7GvjycjaPrffjUYIwhKc-GkMXGD5C7TUDOwiiXAOUsnGDzAxyHhc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.kamada.com\/events-presentations\/<\/a>. The recording replay will be available for 30 days.<\/p>\n<p>Link to webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QPPQ3jDLzmVDekQgsQkoYqK9-ZYmffbkheAF7OfbruR1BK7gb4CBcK0ygm0IddEZ0JzAbZPqglwXYLeVOCDooSlI7IkwbPQkMC4lGR4VRwYCJS4LBYjKo3QFDggu__wSLKkqIE66jmPXzKNd7FgcQqUOFCa0_BheIamq0YDJS2fTUW_Wh9910anvJXLMQ5YD4fP4dNYQLWSBhsgBB76rqMgYDYhTxeVIagUjBiQqBKM=\" rel=\"nofollow\" target=\"_blank\">https:\/\/journey.ct.events\/view\/e756f52e-3889-4b68-aca5-aaf0b71df91d<\/a><\/p>\n<p>\n        <strong>About Kamada <\/strong>\n      <\/p>\n<p align=\"justify\">Kamada Ltd. (the \u201cCompany\u201d) is a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field. FIMI Opportunity Funds, the leading private equity firm in Israel, is the Company\u2019s controlling shareholder, beneficially owning approximately 38% of the outstanding ordinary shares. The Company\u2019s strategy is focused on driving profitable growth through four primary growth pillars: First, organic growth of its commercial portfolio, including continued investment in the commercialization and life cycle management of its proprietary products, consisting of six FDA-approved specialty plasma-derived products: KEDRAB\u00ae, GLASSIA\u00ae, CYTOGAM\u00ae, VARIZIG\u00ae, WINRHO SDF\u00ae and HEPAGAM B\u00ae, as well as KAMRAB\u00ae, and two equine-based anti-snake venom products. Second, distribution of third-parties pharmaceutical products in Israel &amp; the MENA region through in-licensing partnerships, including the launch of several biosimilar products in Israel. Third, the Company is ramping up its plasma collection operations to support revenue growth through the sale of normal source plasma to other plasma-derived manufacturers, and to support its increasing demand for hyper-immune plasma. The Company currently owns three FDA-approved operating plasma collection centers in the United States, in Beaumont, Houston, and San Antonio, Texas. Fourth, the Company aims to secure new mergers and acquisitions, business development, in-licensing and\/or collaboration opportunities, which are anticipated to enhance the Company\u2019s marketed products portfolio and leverage its financial strength and existing commercial infrastructure to drive long-term profitable growth. The Company is leveraging its manufacturing, research and development expertise to advance the development and commercialization of additional product candidates, targeting areas of significant unmet medical need.<\/p>\n<p>\n        <strong>CONTACTS:<\/strong>\n      <\/p>\n<p align=\"justify\">Chaime Orlev<br \/>Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vtB9Vduv0tsFzDQ8AB8A3rW2ic3zF37M2MtF9p4qhJiuBeLY4oLhkO2nYbUN_w-EI10LhtB83N0S4LS3Xn1Tdg==\" rel=\"nofollow\" target=\"_blank\">IR@kamada.com<\/a><\/p>\n<p align=\"justify\">Brian Ritchie<br \/>LifeSci Advisors, LLC<br \/>212-915-2578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7lFx3TjXbFdapcPuQTPKB_wHRFxiqUF6mDtO9dUHd440gyDTO1WEswiuzv5tDFV8UACHAGvp91N2E4Fn2jWhe4g9C8TdzKcjrYBXCdbO-aV7l7HQO3Xs0qsaBiqoHflt\" rel=\"nofollow\" target=\"_blank\">britchie@LifeSciAdvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjAxMzRmNjEtYWRjYy00ZWRlLWExOWYtOWZhOTg2YjYyMjY0LTEwMjg3MjUtMjAyNi0wOS0xMC1lbg==\/tiny\/Kamada-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REHOVOT, Israel, and HOBOKEN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate and present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel. Mr. London is scheduled to present at the conference on Tuesday, September 15, 2026, at 2:30 p.m. Eastern Time. In addition to the presentation, Mr. London will be available for one-on-one investor meetings throughout the conference. Investors that are interested in arranging a meeting should contact their H.C. Wainwright &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1002307","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REHOVOT, Israel, and HOBOKEN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate and present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel. Mr. London is scheduled to present at the conference on Tuesday, September 15, 2026, at 2:30 p.m. Eastern Time. In addition to the presentation, Mr. London will be available for one-on-one investor meetings throughout the conference. Investors that are interested in arranging a meeting should contact their H.C. Wainwright &hellip; Continue reading &quot;Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-10T11:07:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference\",\"datePublished\":\"2026-09-10T11:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"},\"wordCount\":479,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\",\"name\":\"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\",\"datePublished\":\"2026-09-10T11:07:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","og_description":"REHOVOT, Israel, and HOBOKEN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) &#8212; Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate and present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel. Mr. London is scheduled to present at the conference on Tuesday, September 15, 2026, at 2:30 p.m. Eastern Time. In addition to the presentation, Mr. London will be available for one-on-one investor meetings throughout the conference. Investors that are interested in arranging a meeting should contact their H.C. Wainwright &hellip; Continue reading \"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-10T11:07:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference","datePublished":"2026-09-10T11:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"},"wordCount":479,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/","name":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=","datePublished":"2026-09-10T11:07:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyNDQ2NCM3ODI2OTAwIzIwMTcxNTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kamada-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1002307"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1002307\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1002307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1002307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1002307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}